KOSDAQ · Healthcare · ₩30B
₩1,451+0.07%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 2.4% · as of 26.10.28
Among 37 신약 개발 peers
Quarterly Revenue Growth
“진단 시약 판매 회복이 회사의 이익으로 이어진 분기예요.”
In the company's words · 2026 2분기 filing